Another Carlsbad-based company, ChromaCode won for its HDPCR — or high-definition PCR — testing platform, which the company claims provides five times the analytical capacity of any PCR instrument.
The proprietary technology uses digital signal processing, enhanced PCR reagents and cloud-based analytics to significantly increase test capabilities while decreasing costs, according to a news release from ChromaCode.
“Our cloud-based analytics platform, powered by [Amazon Web Services], uniquely enables real-time monitoring of millions of data points from labs in broad geographies,” said ChromaCodeVP of Operations & Data Science Chris MacDonald. “This vast database allows us to instantly assess performance of our products and the instruments they run on, quickly detect and resolve technical issues, evaluate epidemiological trends, and inform on new product development.
“The ChromaCode Cloud also offers labs instant deployment,” MacDonald added. “Using a standard web browser and our proprietary reagents, any lab with a qPCR instrument can be up and running with a new high-throughput test literally overnight.”
ChromaCode’s test received an FDA EUA in September 2020. The company plans to help other emerging test makers to help scale their tests by hosting them on its platform, to develop tests to detect of emerging strain variants and to subsidize tests for schools and businesses that would otherwise not have sound testing programs.